Aripiprazole in the Treatment??of Schizophrenia
- 1 January 2007
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 27 (1) , 1-13
Abstract
Schizophrenia is generally a chronic and disabling mental illness. Pharmacological therapy, which is used for relief of acute psychotic episodes and prevention of subsequent relapse, is essential for...Keywords
This publication has 29 references indexed in Scilit:
- A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA)Schizophrenia Research, 2006
- Medication-Induced HyperprolactinemiaMayo Clinic Proceedings, 2005
- Aripiprazole in schizophrenia: consensus guidelinesInternational Journal Of Clinical Practice, 2005
- Extrapyramidal Symptoms with Atypical AntipsychoticsDrug Safety, 2005
- Low Dopamine D2Receptor Binding in Subregions of the Thalamus in SchizophreniaAmerican Journal of Psychiatry, 2004
- Pharmacokinetics, Tolerability, and Safety of Aripiprazole following Multiple Oral Dosing in Normal Healthy VolunteersThe Journal of Clinical Pharmacology, 2004
- Antipsychotic-Induced HyperprolactinaemiaDrugs, 2004
- Antiepileptic drugs in schizophrenia: a reviewEuropean Psychiatry, 2002
- Delayed Detection of Psychosis: Causes, Consequences, and Effect on Public HealthAmerican Journal of Psychiatry, 2000
- The Core Symptoms of SchizophreniaAnnals of Medicine, 1996